Literature DB >> 34609574

Minimally Invasive Versus Open Radical Antegrade Modular Pancreatosplenectomy: A Meta-Analysis.

Eric Jinyi Wu1, Tousif Kabir2,3, Joseph J Zhao1, Brian K P Goh4,5.   

Abstract

BACKGROUND: Radical antegrade modular pancreatosplenectomy (RAMPS) was introduced to improve the tangential resection margin rates and N1 node clearance following resection of malignancies of the pancreatic body and tail. Owing to its technical complexity, minimally invasive RAMPS (MI-RAMPS) has only been reported by a few centers worldwide. We performed this meta-analysis to compare both short- and long-term outcomes between open RAMPS (O-RAMPS) and minimally invasive RAMPS (MI-RAMPS).
METHODS: A systematic search of the electronic databases PubMed, Medline (via PubMed), Cochrane Register of Controlled Trials (CENTRAL), EMBASE, Scopus and Web of Science was performed to identify eligible studies published in the English language regardless of study design. The outcomes of interest were operation time, estimated blood loss, transfusion rates, overall complications, Grade B/C post-operative pancreatic fistula (POPF) rates, post-pancreatectomy hemorrhage (PPH), delayed gastric emptying (DGE), length of stay (LOS), R0 resection rates, lymph node (LN) yield and overall survival (OS).
RESULTS: Five non-randomized studies comprising of a total 229 patients (89 MI-RAMPS, 140 O-RAMPS) were included for analysis. Intra-operative blood loss was observed to be significantly reduced in MI-RAMPS as compared to O-RAMPS (MD -256.16, P < 0.001), while LN yield was higher in O-RAMPS as compared to MI-RAMPS (MD -2.73, P = 0.02). There were no statistically significant differences observed for the other perioperative, oncologic and survival outcomes.
CONCLUSIONS: This meta-analysis provides early evidence to suggest that MI-RAMPS may produce comparable short- and long-term outcomes to O-RAMPS, when undertaken by appropriately skilled surgeons in well-selected patients. Further large-scale prospective studies are required to corroborate these findings.
© 2021. Société Internationale de Chirurgie.

Entities:  

Mesh:

Year:  2021        PMID: 34609574     DOI: 10.1007/s00268-021-06328-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Radical antegrade modular pancreatosplenectomy.

Authors:  Steven M Strasberg; Jeffrey A Drebin; David Linehan
Journal:  Surgery       Date:  2003-05       Impact factor: 3.982

2.  Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial.

Authors:  J P Neoptolemos; D D Stocken; J A Dunn; J Almond; H G Beger; P Pederzoli; C Bassi; C Dervenis; L Fernandez-Cruz; F Lacaine; J Buckels; M Deakin; F A Adab; R Sutton; C Imrie; I Ihse; T Tihanyi; A Olah; S Pedrazzoli; D Spooner; D J Kerr; H Friess; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

Review 3.  Improvement of surgical results for pancreatic cancer.

Authors:  Werner Hartwig; Jens Werner; Dirk Jäger; Jürgen Debus; Markus W Büchler
Journal:  Lancet Oncol       Date:  2013-10       Impact factor: 41.316

4.  Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?

Authors:  Ioannis T Konstantinidis; Vikram Deshpande; Hui Zheng; Jennifer A Wargo; Carlos Fernandez-del Castillo; Sarah P Thayer; Vasiliki Androutsopoulos; Gregory Y Lauwers; Andrew L Warshaw; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

5.  Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy.

Authors:  C G Willett; K Lewandrowski; A L Warshaw; J Efird; C C Compton
Journal:  Ann Surg       Date:  1993-02       Impact factor: 12.969

6.  Pancreatic adenocarcinoma: the actual 5-year survivors.

Authors:  Cristina R Ferrone; Murray F Brennan; Mithat Gonen; Daniel G Coit; Yuman Fong; Sun Chung; Laura Tang; David Klimstra; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 7.  Left-sided pancreatic cancer: distal pancreatectomy and its variants: radical antegrade modular pancreatosplenectomy and distal pancreatectomy with celiac axis resection.

Authors:  Steven M Strasberg; Ryan Fields
Journal:  Cancer J       Date:  2012 Nov-Dec       Impact factor: 3.360

8.  Comparison of Radical Antegrade Modular Pancreatosplenectomy with Standard Retrograde Pancreatosplenectomy for Left-Sided Pancreatic Cancer: A Meta-Analysis and Experience of a Single Center.

Authors:  Zhen Huo; Shuyu Zhai; Yue Wang; Hao Qian; Xiaomei Tang; Yusheng Shi; Yuanchi Weng; Shulin Zhao; Xiaxing Deng; Baiyong Shen
Journal:  Med Sci Monit       Date:  2019-06-21

Review 9.  Optimizing the outcomes of pancreatic cancer surgery.

Authors:  Oliver Strobel; John Neoptolemos; Dirk Jäger; Markus W Büchler
Journal:  Nat Rev Clin Oncol       Date:  2019-01       Impact factor: 66.675

Review 10.  Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.

Authors:  Andrew McGuigan; Paul Kelly; Richard C Turkington; Claire Jones; Helen G Coleman; R Stephen McCain
Journal:  World J Gastroenterol       Date:  2018-11-21       Impact factor: 5.742

View more
  3 in total

1.  A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study.

Authors:  Huaqing Shi; Zhou Chen; Shi Dong; Ru He; Yan Du; Zishun Qin; Wence Zhou
Journal:  BMC Gastroenterol       Date:  2022-06-03       Impact factor: 2.847

2.  Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreatic ductal adenocarcinoma surgical resection.

Authors:  Nan Niu; Yuhui He; Yiping Mou; Sijia Meng; Peng Xu; Yucheng Zhou; Weiwei Jin; Chao Lu; Yunyun Xu; Qicong Zhu; Tao Xia
Journal:  Front Surg       Date:  2022-09-01

3.  The effect of minimally invasive or open radical antegrade modular pancreatosplenectomy on pancreatic cancer: A multicenter randomized clinical trial protocol.

Authors:  Menghua Dai; Hanyu Zhang; Yinmo Yang; Dianrong Xiu; Bing Peng; Bei Sun; Feng Cao; Zheng Wu; Lei Wang; Chunhui Yuan; Hua Chen; Zheng Wang; Xiaodong Tian; Hangyan Wang; Wenjing Liu; Jianwei Xu; Qiaofei Liu; Yupei Zhao
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.